Parth Khanna
January 1, 2026
ACTO announced that its AI-powered field simulation platform, CxZone, earned dual honors at the 2025 Pharmaceutical Technology Excellence Awards, winning in both the Innovation (AI Roleplay) and Product Launches (Field Simulation) categories. Designed to address persistent gaps between headquarters strategy and real-world HCP conversations, CxZone uses ACTO’s proprietary Empathetic AI to deliver realistic, judgment-free simulations that improve clinical fluency, messaging, and engagement effectiveness for field professionals. An industry first, the platform integrates directly with Veeva Vault PromoMats and MedComms, ensuring all practice scenarios are built on the most current MLR-approved content. With gamified, on-demand roleplay, personalized feedback, and an intuitive backend that allows rapid scenario creation, CxZone enables sales reps and MSLs to practice authentic clinical conversations efficiently while enhancing training effectiveness and HCP engagement.
“This recognition validates our purpose-built approach to develop CxZone, which was to empower field reps to show up in the most human way possible,” said Parth Khanna, CEO of ACTO. “CxZone can help field professionals rehearse difficult conversations, test different approaches, and build confidence. By helping field professionals speak the language of medicine with clarity and confidence, interactions with healthcare providers can be authentic in the moment and build more trust.”